Daqing Wang
35Patents
9h-index
15Co-inventors
68Inventor score
Filing activity: May 14, 2004 → Oct 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8431544B1 | Compositions for inhibiting gene expression and uses thereof | Chemistry; Metallurgy | 45 | Active |
| US9453228B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Chemistry; Metallurgy | 20 | Active |
| US7569554B2 | Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents | Chemistry; Metallurgy | 15 | Expired |
| US8426375B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 14 | Active |
| US7960362B2 | Synthetic agonists of TLR9 | Human Necessities | 14 | Active |
| US8853375B2 | Toll like receptor modulators | Emerging Cross-Sectional Technologies | 13 | Active |
| US8377898B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Chemistry; Metallurgy | 10 | Active |
| US7884197B2 | Synthetic agonists of TLR9 | Chemistry; Metallurgy | 10 | Active |
| US8188261B2 | Stabilized immune modulatory RNA (SIMRA) compounds | Chemistry; Metallurgy | 10 | Active |
| US8361986B2 | Synthetic agonists of TLR9 | Human Necessities | 9 | Active |
| US8486908B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 8 | Active |
| US7875594B2 | Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents | Chemistry; Metallurgy | 8 | Active |
| US8399423B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Chemistry; Metallurgy | 7 | Active |
| US8106173B2 | Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 | Chemistry; Metallurgy | 7 | Active |
| US8383598B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 7 | Active |
| US8357665B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Chemistry; Metallurgy | 7 | Active |
| US10463686B2 | Immune modulation with TLR9 agonists for cancer treatment | Chemistry; Metallurgy | 5 | Active |
| US8362233B2 | Stabilized immune modulatory RNA (SIMRA) compounds | Chemistry; Metallurgy | 5 | Active |
| US9260719B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 5 | Active |
| US9243050B2 | Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 | Chemistry; Metallurgy | 5 | Active |
| US9096858B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 5 | Active |
| US9206430B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Chemistry; Metallurgy | 4 | Active |
| US8759310B2 | Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 | Chemistry; Metallurgy | 4 | Active |
| US8202974B2 | Synthetic RNA-based agonists of TLR7 | Chemistry; Metallurgy | 4 | Active |
| US9540651B2 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.